MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-28-2026
QIAGEN N.V. Cash Conversion Cycle 2011-2026 | QGEN
Annual Cash Conversion Cycle QIAGEN N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 122 | 149 | 151 | 152 | 145 | 153 | 161 | 152 | 152 | 161 | 141 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 161 | 122 | 149 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
111 | $ 119.98 | 0.83 % | $ 36.5 B |  USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.93 | 3.53 % | $ 95.1 K | USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 23.2 | -1.44 % | $ 247 M |  China |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
45.9 | $ 27.88 | 1.12 % | $ 774 M | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 177.64 | 1.03 % | $ 8.8 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 13.72 | -0.54 % | $ 415 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
41.7 | $ 15.46 | -0.26 % | $ 2 B | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.12 | - | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 208.13 | -0.11 % | $ 23.1 B | USA |
 |
Danaher Corporation
DHR
|
77.5 | $ 204.09 | 0.02 % | $ 145 B | USA |
 |
Organovo Holdings
ONVO
|
-82.8 K | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | $ 103.35 | -0.02 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
208 | $ 8.62 | -1.37 % | $ 540 M | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 10.3 | - | $ 292 M | Israel |
 |
DexCom
DXCM
|
134 | $ 71.8 | -1.75 % | $ 28 B | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
45.3 | - | -1.84 % | $ 15.3 M | USA |
 |
IDEXX Laboratories
IDXX
|
103 | $ 632.85 | -0.42 % | $ 50.9 B | USA |
 |
Illumina
ILMN
|
142 | $ 130.71 | 0.89 % | $ 20.8 B | USA |
 |
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
62 | $ 108.37 | -0.3 % | $ 8.94 B |  Irlanda |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |  Britain |
 |
CareDx, Inc
CDNA
|
51.5 | $ 18.76 | -0.21 % | $ 1 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Guardant Health
GH
|
79.6 | $ 93.57 | 0.28 % | $ 11.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 281.62 | -0.51 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 78.82 | -0.03 % | $ 5.32 B | USA |
 |
IQVIA Holdings
IQV
|
73.9 | $ 175.43 | 0.82 % | $ 30.2 B | USA |
 |
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 316.93 | 0.07 % | $ 27.1 B | Schweiz |
 |
Myriad Genetics
MYGN
|
49.3 | $ 5.32 | 0.47 % | $ 493 M | USA |